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Targeted inhibition of multidrug ABCG2 transporter is believed to improve cancer therapeutics.
However, the consequences of ABCG2 inhibition have not been systematically evaluated since ABCG2
is expressed in several organs including the liver. Here, we demonstrate that ABCG2-deﬁcient hepa-
tocytes have increased amounts of fragmental mitochondria accompanied by disruption of mito-
chondrial dynamics and functions. This disruption was due to ABCG2 knockout elevating
intracellular protoporphyrin IX, which led to upregulation of DRP-1-mediated mitochondrial ﬁs-
sion. The ﬁnding that ABCG2 deﬁciency can generate dysfunctional mitochondria in hepatocytes
raises concerns regarding the systematic use of ABCG2 inhibitor in cancer patients.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction Recent work has shown that ABCG2 plays a role in enhancingThe ATP-binding cassette transporter ABCG2, also known as
breast cancer resistance protein (BCRP), was ﬁrst discovered in
doxorubicin-resistant breast cancer cells [1]. Studies have subse-
quently shown that ABCG2 is expressed not only in drug-resistant
cancer cells, but also in a wide variety of stem cells and in numer-
ous adult tissues including the liver, kidney, intestine, and placenta
[2]. However, its physiological role remains unclear and the effects
of ABCG2 depletion in adult tissues have not been thoroughly
addressed.the survival of haematopoetic stem cells under hypoxic conditions,
possibly via the transport of heme and porphyrins [3]. We previ-
ously demonstrated that ABCG2 is expressed in undifferentiated
embryonic stem (ES) cells and that the ABCG2 transporter protects
these cells from protoporphyrin IX (PPIX) accumulation during col-
ony expansion [4]. However, whether ABCG2 depletion in ABCG2-
expressing tissues can lead to disruption of porphyrin homeostasis
has not yet been explored.
Hepatocytes are endowed with several ATP-binding cassette
transporters whose function is to mediate bile excretion at the can-
alicular membrane [5]. ABCG2 is expressed in the hepatic canalicu-
lar membrane and is believed to play a role in the secretion of bile
[6]. Increasing levels of ABCG2 were found to associate oval-cell
dependent liver regeneration and pancreas-to-liver transdifferenti-
ation [7,8]. The ﬁndings suggest that ABCG2 may be an essential
transporter for liver. To determine the consequence of ABCG2deple-
tion in liver, in this study, we have generated ABCG2 knockout mice
and utilized to evaluate the possible role of ABCG2 in hepatocytes.
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2.1. Mice
All animal experiments were approved by the Academia Sini-
ca Institutional Animal Care and Utilization Committee. Both ﬂo-
xed ABCG2 mice and beta actin L-Cre transgenic mice were
obtained from the Mutant Mouse Regional Resource Centre
(MMRRC at the University of Missouri). Constitutive ABCG2
knockout mice were generated by cross-breeding b-actin L-Cre
mice to ﬂoxed ABCG2 mice, which resulted in a 1.3 Kb deletion
of exon2 that contained the translation initiation codon
(Fig. 1A).Fig. 1. Generation and characterization of ABCG2 knockout mice. (A) Schematic repres
ABCG2 mice with beta actin L-Cre mice. (B) RT-PCR analysis of mRNA isolated from the li
isolated from the liver of ABCG2+/+, ABCG2+/, and ABCG2/ mice using anti-ABCG2 an
staining for ABCG2 (J–L) on liver sections obtained from ABCG2+/+ (D, G, J), ABCG2+/ (E, H
liver of ABCG2 knockout mice.2.2. Measurements of oxygen consumption rate (OCR) and
extracellular acidiﬁcation rate (ECAR)
All measurements utilized the Seahorse XF24 Flux Analyzer
(Seahorse Biosciences, Billerica, MA). To determine the immediate
response of hepatocytes from ABCG2+/+ and ABCG2/mice, freshly
isolated hepatocytes were seeded for 30 min on 24-well micro-
plates pre-coated with Cell-Tak™ Cell and Tissue Adhesive (BD Bio-
sciences). To determine responses of hepatocytes treated with or
without ALA, primary hepatocytes isolated from ABCG2+/+ and
ABCG2/ mice were seeded on XF24-well microplates at 1  104
cells/well and were incubated at 37 C overnight. Assay medium
(625 ll), was added to each well and baseline levels of oxygenentation of the strategy used to generate ABCG2 knockout mice by crossing foxed
ver of ABCG2+/+, ABCG2+/, and ABCG2/mice. (C) Western blot analysis of proteins
d anti-b-actin antibodies. H&E staining (D–F), PAS (G–I) and Immunohistochemical
, K) and ABCG2/ (F, I, L) mice. The arrows point out inﬁltration of leukocytes in the
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extracellular acidiﬁcation rate [ECAR]) were obtained. Next, com-
plex V was blocked by addition of 1 lM OLIGO and measurements
were taken. One micromolar FCCP was then added to permeabilize
the mitochondrial inner membranes and uncouple electron trans-
port from the oxidative phosphorylation system. Finally, injection
of 1 lM of ANTI can inhibit complex III which would lead to cessa-
tion of both electron ﬂow and oxygen consumption. Experiments
were performed by simultaneously measuring three replicates
from each experimental group. The representative effects were ex-
pressed as areas under the curve measurements generated using
the manufacturer’s software.
2.3. JC-1 staining
JC-1 is a lipophilic carbocyanine that exists as a monomer
(green color) and accumulates in depolarized mitochondria. In
the presence of a high mitochondrial membrane potential, JC-1
can reversibly form aggregates (red color). JC-1 staining was per-
form as described previously [9]. Primary hepatocytes isolated
from ABCG2+/+ and ABCG2/mice, with or without ALA treatment,
were stained with 5 lg/ml JC-1 for 20 min at 37 C. Images were
obtained with a Zeiss Axiovert 200 M inverted ﬂuorescence micro-
scope. Fluorescence intensity of JC-1 staining was analyzed using
Image J software (NIH, USA).
2.4. MitoTracker staining and mitochondrial morphology analysis
MitoTracker Red CMXRos (Molecular Probes, Invitrogen) was
used to stain primary hepatocytes. MitoTracker Red stains mito-
chondria in living cells and its accumulation is dependent upon
membrane potential. Live cell images were captured by a Zeiss
Axiovert 200 M inverted microscope and mitochondrial staining
of hepatocytes was analyzed using Image J (NIH, USA) and the
staining pattern was validated by the Micro-P software [10,11].
Individual mitochondria in hepatocytes were stained with Mito-
Tracker dye and categorized as one of three types based on area,
morphology, and length. Mitochondria larger than 20  20 pixels
were classiﬁed as type 1 (large fused mitochondria); non-round
mitochondria longer than 20 pixels were classiﬁed as type 2 (elon-
gated mitochondria); and mitochondria with either a diameter less
than 20 pixels or an overall size less than 20  20 pixels were clas-
siﬁed as type 3 (small segregated mitochondria). For each condi-
tion, a total of 100 hepatocytes were evaluated and data were
averaged from three independent experiments.
2.5. Flow cytometric analysis of intracellular PPIX
Determination of intracellular levels of PPIX was carried out as
previously described [4]. To determine if ABCG2 knockout or inhi-
bition in hepatocytes can affect PPIX efﬂuxing, primary hepato-
cytes isolated from ABCG2+/+ and ABCG2/ mice were incubated
for 45 min at 37 C in complete media with 10 mM ALA followed
by a 2 h incubation in fresh media with or without fumitremorgin
C (FTC) before PPIX levels were obtained using UV laser excitation
and measuring the emission using a 635 nm ﬁlter with Vantage
ﬂow cytometry (BD Biosciences).
2.6. Determination of the mitochondrial and cytosolic levels of PPIX
using UV spectroﬂuorometer
Determination of mitochondrial and cytosolic levels of PPIX was
carried out as previously described with some modiﬁcation [12].
Brieﬂy, the cytosolic fraction of hepatocytes was mixed with meth-
anol–perchloric acid following by centrifugation to remove precip-
itated proteins. The supernatant was used for ﬂuorescencemeasurements using a HORIBA Fluorolog-3 spectroﬂuorometer
system. The mitochondrial fraction of hepatocytes was disrupted
in 0.1 M NaOH containing 0.1% SDS. After 1 h of incubation, the
solution was then mixed with methanol–perchloric acid following
by centrifugation to remove precipitated proteins. The supernatant
was used for ﬂuorescence measurements using a HORIBA Fluoro-
log-3 spectroﬂuorometer system. The bandwidth of excitation
and emission slits was set at 5 and 2 nm, respectively. Under an
excitation wavelength of 400 nm, the ﬂuorescent emission from
500 to 750 nm was recorded (the peak of PPIX ﬂuorescence ap-
peared at 605 nm).
2.7. Statistical analysis
All values were represented mean ± standard error of the mean
(S.E.M.). The comparison between control and experimental groups
was considered as signiﬁcant when P value is less than 0.05. And
the statistical signiﬁcance was determined using a nonparametric
statistical test, Mann–Whitney test or Kruskal–Wallis test.3. Results
3.1. A reduction in glycogen storage in the liver of ABCG2 knockout
mice
In order to examine the consequence of ABCG2 depletion in li-
ver, constitutive abcg2 knockout mice were generated by cross-
breeding b-actin L-Cre mice to ﬂoxed ABCG2 mice, which resulted
in a 1.3 Kb deletion of exon2 containing the translation initiation
codon (Fig. 1A). Examination of bone marrow cells from abcg2
knockout mice revealed that the SP phenotype was reduced by
75% compared with wild-type (Supplementary Fig. 1A), conﬁrming
the loss of ABCG2 in these cells. Real-time PCR and Western blot
analysis showed that an aberrant abcg2 transcript (lacking exon2)
was generated, but no ABCG2 protein was produced in the liver
(Fig. 1B and C), and immunohistochemical staining further con-
ﬁrmed the loss of ABCG2 protein in hepatocytes (Fig. 1J–L). To
examine the consequence of ABCG2 depletion in adult mice, liver
morphology and function were studied. Hematoxylin and eosin
(H&E) staining showed occasional inﬁltration of leukocytes in the
liver of ABCG2 knockout mice (Fig. 1D–F), but no signiﬁcant alter-
ation in liver morphology was observed. Glucose tolerance testing
showed that ABCG2 knockout mice had an altered pattern of glu-
cose utilization (Supplementary Fig. 1B). Periodic acid–Schiff
(PAS) staining indicated that there was a reduction in glycogen
storage in the liver of ABCG2 knockout mice (Fig. 1G–I), suggesting
that reduced glycogen may cause this altered glucose homeostasis.
3.2. An increase in fragmental mitochondria in ABCG2-deﬁcient
hepatocytes
Glutamine synthetase (GS) is almost exclusively expressed in
pericentral hepatocytes surrounding the central vein [13]. GS and
E-cadherin were stained to determine if liver zonation was altered
in ABCG2 knockout mice (Fig. 2A–C, F–H). Though the hepatic
zonation was not signiﬁcantly altered in ABCG2 knockout mice, a
comparison with wild-type mice showed that GS staining was den-
ser and was more scattered in the periportal zones in the knockout
mice (Fig. 2C and H). As GS is a mitochondrial protein that is in-
volved in ammonia clearance and the production of glutamine
[14], we then examined whether mitochondrial distribution was
affected by ABCG2 knockout. Transmission electron microscopy
(TEM) revealed that the mitochondria of ABCG2-deﬁcient hepato-
cytes were fragmented and had distorted cristae structure com-
pared with mitochondria from wild-type hepatocytes (Fig. 2D, E,
Fig. 2. ABCG2 knockout in hepatocytes led to impairment in mitochondrial dynamics and function. (A–C, F–H) Immunohistochemical staining for E-cadherin and GS on liver
sections obtained from ABCG2+/+ (A–C) and ABCG2/ (F–H) mice. (C and H) Zoomed images of boxed regions in (B and G). (D, E, I, J) Transmission electron microscopy of liver
sections obtained from ABCG2+/+ (D and E) and ABCG2/ (I and J) mice. (E and J) Zoomed images of boxed regions in (D and I). (K and N) JC-1 staining of primary hepatocytes
isolated from ABCG2+/+ (K) and ABCG2/ (N) mice. (Q) Quantitation analysis of J-aggregates (red) and JC-1 monomer (green) staining of primary hepatocytes isolated from
ABCG2+/+ and ABCG2/ mice. Data shown were averaged from images of 8 different regions. ⁄⁄P < 0.01 indicates the difference between wild-type and ABCG2 knockout
hepatocytes was statistically signiﬁcant. (L, M, O, P) MitoTracker Red staining of primary hepatocytes isolated from ABCG2+/+ (L and M) and ABCG2/ (O and P) mice. (M and
P) Zoomed images of boxed regions in (L and O). (R) Quantitation analysis of the mitochondrial morphology on MitoTracker Red staining of primary hepatocytes isolated from
ABCG2+/+ and ABCG2/mice. The mitochondrial morphology was classiﬁed into elongated, large fused and small segregate types. Data shown are averaged percentages from
images of 8 different regions. ⁄⁄P < 0.01 indicates the difference between wild-type and ABCG2 knockout hepatocytes was statistically signiﬁcant. (S–W) XF24 Extracellular
Flux Analyzer was utilized to analyze OCR (S) and ECAR (T) of hepatocytes freshly isolated from ABCG2+/+ and ABCG2/ mice. ABCG2+/+ and ABCG2/ hepatocytes were
exposed sequentially to OLIGO, FCCP, and ANTI. Values are mean ± S.E.M. (n = 3). (U–W) Summary of basal respiration (U), ATP production (V), and maximal respiration (W).
Mean ± S.E.M., n = 3. ⁄⁄P < 0.01 indicate the difference between wild-type and ABCG2 knockout hepatocytes was statistically signiﬁcant.
Y.-H. Lin et al. / FEBS Letters 587 (2013) 3202–3209 3205I, J). ABCG2-deﬁcient hepatocytes also had an altered endoplasmic
reticulum network (Fig. 2I and J).
3.3. ABCG2 knockout leading to impairment in mitochondrial
dynamics and function
In order to investigate if the change in mitochondrial structure
was accompanied by altered mitochondrial function, mitochon-
drial membrane potentials in primary hepatocytes from ABCG2/
 and ABCG2+/+ mice were compared using JC-1 dye, which exists
either as a green-ﬂuorescent monomer at depolarized membrane
potentials or as a red-ﬂuorescent J-aggregate at hyperpolarized
membrane potentials (Fig. 2K and N). Average intensities of red
aggregates and green monomers were calculated. As shown in
Fig. 2Q, ABCG2-deﬁcient hepatocytes had nearly twofold fewer
red JC-1 aggregates than wild-type hepatocytes (Fig. 2K, N, Q).
MitoTracker Red staining was further utilized to determine the cor-
relation of mitochondrial morphology and membrane potential
(Fig. 2L, M, O, P). As shown in Fig. 2R, approximately 7.8% and5.3% of the mitochondria from wild-type hepatocytes were large
fused and elongated compared with 0.5% and 2.1% in ABCG2-deﬁ-
cient hepatocytes (Fig. 2R). These large fused and elongated mito-
chondria showed intense red staining, suggesting that ABCG2
knockout leads to the generation of more fragmented mitochon-
dria under predominately low membrane potential conditions. In
order to determine if basal levels of oxidative phosphorylation
(OXPHOS) were also affected, the XF24 Extracellular Flux Analyzer
was used to measure oxygen consumption rate (OCR). Primary
hepatocytes isolated from ABCG2/ and ABCG2+/+ mice were
sequentially exposed to three metabolic inhibitors in order to
determine their bioenergetic capabilities: oligomycin (OLIGO),
which blocks the ATP synthase activity of Complex V and leads
to the cessation of respiration; carbonyl cyanide 4-triﬂuorometh-
oxy-phenylhydrazone (FCCP), which is an uncoupler (the increase
in FCCP-mediated OCR provides a measurement of the maximum
respiratory rate of cells); and lastly, antimycin-A (ANTI), which
inhibits complex III and results in the complete cessation of elec-
tron ﬂow and oxygen consumption. As shown in Fig. 2S, wild-type
3206 Y.-H. Lin et al. / FEBS Letters 587 (2013) 3202–3209hepatocytes had a higher rate of cellular oxygen consumption re-
lated to ATP synthesis compared with ABCG2-deﬁcient hepato-
cytes (58% vs 47%). Thus, ABCG2 knockout reduced baseline
OXPHOS, maximal respiratory rate, and ATP production capability
(Fig. 2U–W). These ﬁndings were conﬁrmed by concomitant mea-
surements of the extracellular acidiﬁcation rate (ECAR) (Fig. 2T)
and suggest that ABCG2 knockout in the liver not only leads to
changes in mitochondrial structure, but also to impairment of
mitochondrial function.
3.4. Efﬂuxing of excessive PPIX is mediated by the ABCG2 transporter
in mouse hepatocytes
To further address whether ABCG2 depletion in liver can lead to
disruption of porphyrin homeostasis, we used ﬂow cytometry to
examine PPIX levels in primary hepatocytes isolated fromFig. 3. ABCG2 knockout or ALA treatment increased mitochondrial and cytosolic levels of
ﬂow cytometry for primary hepatocytes isolated from ABCG2+/+ and ABCG2/mice. (B an
+ and ABCG2/ mice were analyzed by a UV spectroﬂuorometer. Peak of PPIX ﬂuoresc
mitochondrial fractions of hepatocytes were shown by red line (ABCG2 knockout) and
ABCG2/ mice were pretreated with ALA with or without FTC for 45 min followed by a
cytosolic and mitochondrial fractions of ALA-treated and untreated hepatocytes were iso
at 605 nm indicated by arrow. The levels of PPIX of cytosolic and mitochondrial fractio
control). (G–J) The XF24 Extracellular Flux Analyzer was utilized to analyze OCR (G) of
10 mM ALA treatment. ABCG2+/+ and ABCG2/ hepatocytes exposed sequentially to O
respiration (H), ATP production (I), and maximal respiration (J). Mean ± S.E.M., n = 3. ⁄⁄⁄P
statistically signiﬁcant.ABCG2/ and ABCG2+/+ mice. Endogenous levels of PPIX were
found to be greater in ABCG2-deﬁcient hepatocytes compared to
wild-type hepatocytes (Fig. 3A). In order to address whether there
was difference of intracellular PPIX levels between wild-type and
ABCG2-deﬁcient hepatocytes, we have carried out statistical anal-
ysis using 2-tailed Mann–Whiney Test or Kruskal–Wallis Test on
ﬂuorescent intensity between two populations. Both test showed
the P value was <0.0001 suggested there was signiﬁcant difference
of intracellular PPIX levels between wild-type and ABCG2-KO
hepatocytes. In addition, we have also analyzed the mitochondrial
and cytosolic levels of PPIX using UV spectroﬂuorometer (the peak
emission of PPIX is at 605 nm) (Fig. 3B and C). The results which
showed both mitochondrial and cytosolic fractions of ABCG2-deﬁ-
cient hepatocytes had higher levels of PPIX compared to the frac-
tions isolated from wild-type hepatocytes. Furthermore, Western
blot analysis and immunoﬂuorescent staining conﬁrmed thatPPIX led to disruption of mitochondrial function. (A) PPIX ﬂuorescence measured by
d C) The cytosolic and mitochondrial fractions of hepatocytes isolated from ABCG2+/
ent emission is at 605 nm indicated by arrow. The levels of PPIX of cytosolic and
blue line (ABCG2 wild-type). (D) Primary hepatocytes isolated from ABCG2+/+ and
2 h incubation. PPIX ﬂuorescence was determined by ﬂow cytometry. (E and F) The
lated and analyzed by a UV spectroﬂuorometer. Peak of PPIX ﬂuorescent emission is
ns of hepatocytes were shown by red line (ALA-treated) and blue line (untreated
primary hepatocytes isolated from ABCG2+/+ and ABCG2/ mice with or without
LIGO, FCCP, and (ANTI. The value shown is mean ± S.E.M. (H–J) Summary of basal
< 0.005 indicates the difference between control and ALA-treated hepatocytes was
Y.-H. Lin et al. / FEBS Letters 587 (2013) 3202–3209 3207ABCG2 was also expressed in mitochondria (Supplementary Fig. 2B
and E). These results suggest that ABCG2 is a key transporter to
regulate both mitochondrial and cytosolic levels of PPIX.
Primary hepatocytes were then treated with 10 mM d-amino-
levulinic acid (ALA) for 45 min and allowed to incubate for 2 h to
induce the synthesis of PPIX. This treatment signiﬁcantly increased
the level of PPIX in both wild-type and ABCG2-deﬁcicent hepato-
cytes (Fig. 3D). Statistical analysis was applied on ﬂuorescent
intensity between two wild-type and ALA-treated hepatocytes,
both Mann–Whiney Test and Kruskal–Wallis Test showed the P va-
lue was <0.0001 conﬁrmed that ALA treatment could signiﬁcantly
increase the intracellular PPIX levels. Moreover, we have also val-
idated the increases of the mitochondrial and cytosolic levels of
PPIX using UV spectroﬂuorometer in ALA-treated hepatocytes
(Fig. 3E and F). Most importantly, we found that hepatocytes which
were pretreated with fumitremorgin C (FTC), an inhibitor of
ABCG2, had higher levels of PPIX compared with wild-type hepato-
cytes in the present of ALA (Fig. 3D). Statistical analysis using 2-
tailed Mann–Whiney Test showed the P value was <0.05 conﬁrmedFig. 4. Excessive PPIX accumulation impaired mitochondrial dynamics and function. (A a
D) and ABCG2/ (B) mice without (A–C) or with (D) ALA treatment. (E) Quantitation
hepatocytes isolated from ABCG2+/+ mice without or with ALA treatment. The mitochondr
Data shown are averaged percentages from images of 6 different regions. ⁄⁄P < 0.01 and
statistically signiﬁcant. (F–H) JC-1 staining of primary hepatocytes isolated from ABCG2+/
of J-aggregates (red) and JC-1 monomer (green) staining of primary hepatocytes witho
regions. ⁄⁄⁄P < 0.005 indicates the difference between control and ALA-treated hepatocy
mRNA expression levels of drp1 in hepatocytes of ABCG2+/+ and ABCG2/ mice norma
⁄⁄P < 0.01 indicate the difference between wild-type and ABCG2-deﬁcicent hepatocytes w
expression level of drp1 in primary hepatocytes isolated from wild-type mice that were tr
least three independent experiments. ⁄P < 0.05 indicate the difference between untreate
microscopic images obtained from co-staining of MitoTracker Red and DRP1 (K–N) or p-D
(M, N, Q, R) Zoomed images of boxed region in (K, L, O, P).that ALA treatment could signiﬁcantly increase the intracellular
PPIX levels in FTC-pretreated hepatocytes suggesting that efﬂuxing
of excessive PPIX are mediated by the ABCG2 transporter in mouse
hepatocytes.
3.5. PPIX accumulation induce DRP-1-mediated mitochondria ﬁssion
Since ABCG2 deﬁciency or inhibition can lead to PPIX accumu-
lation, we investigated whether increased levels of intracellular
PPIX could lead to impairment in mitochondria function using
the XF24 Extracellular Flux Analyzer. One-day cultured primary
hepatocytes isolated from ABCG2/ and ABCG2+/+ mice were incu-
bated with 2 mM ALA for 6 h and then were sequentially exposed
to three metabolic inhibitors in order to determine if the bioener-
getic capability was affected by PPIX accumulation. As shown in
Fig. 3G, ALA treatment signiﬁcantly reduced baseline OXPHOS,
maximal respiratory rate, and ATP production capability
(Fig. 3H–J). As shown in Fig. 2 and 4A, B, primary hepatocytes
freshly isolated from wild-type mice contained approximatelynd D). Mitotracker red staining of primary hepatocytes isolated from ABCG2+/+ (A, C,
analysis of the mitochondrial morphology on MitoTracker Red staining of primary
ial morphology was classiﬁed into elongated, large fused, and small segregate types.
⁄P < 0.05 indicate the difference between control and ALA-treated hepatocytes was
+ mice were treated without (G) or with ALA treatment (H). (F) Quantitation analysis
ut or with ALA treatment. Data shown were averaged from images of 6 different
tes was statistically signiﬁcant. (I) Real-time quantitative RT-PCR showing relative
lized to gapdh. Data were calculated from at least three independent experiments.
as statistically signiﬁcant. (J) Real-time quantitative RT-PCR showing relative mRNA
eated with or without ALA for 6 h normalized to gapdh. Data were calculated from at
d control and ALA-treated hepatocytes was statistically signiﬁcant. (K–R) Confocal
RP1 (O–R) on untreated control (K, M, O, Q) and ALA-treated hepatocytes (L, N, P, R).
3208 Y.-H. Lin et al. / FEBS Letters 587 (2013) 3202–320913% mitochondria that were either large fused or elongated com-
pared with of approximately 3% in ABCG2-deﬁcient hepatocytes.
Similarly, we also found one-day cultured primary hepatocytes iso-
lated from wild-type mice contained approximately 11.5% mito-
chondria that were either large fused or elongated compared
with 3.7% in ALA-treated hepatocytes (Fig. 4C–E). These results
suggest that ABCG2 knockout in the liver increased intracellular
levels of PPIX, which very likely caused impairment in mitochon-
drial function via disruption of mitochondrial fusion/ﬁssion bal-
ance. To determine if PPIX accumulation could lead to alterations
in mitochondrial membrane potential and disruption of mitochon-
drial fusion/ﬁssion balance, one-day cultured primary hepatocytes
were treated with 2 mM ALA for 6 h and then stained with JC-1 and
MitoTracker Red. When the average intensities of red JC-1 aggre-
gates and green monomers were calculated, ALA-treated hepato-
cytes showed nearly threefold less red JC-1 aggregates than
control hepatocytes (Fig. 4F–H).
To further determine how ABCG2 knockout or PPIX accumula-
tion can disrupt mitochondrial fusion/ﬁssion balance, we have
examined the expression level of the mitochondrial fusion/ﬁssion
regulator including dynamin-related protein 1 (DRP-1), mitofu-
sin-1 (MFN-1) and inner membrane dynamin-related protein
OPA-1 (Fig. 4I, Supplementary Fig. 2A and B). As shown in Fig. 4I,
real-time quantitative RT-PCR showed the level of drp-1 in
ABCG2-deﬁcicent hepatocytes was twofold higher than wild-type
hepatocytes. Western blot analysis further conﬁrmed mitochon-
drial and cytosolic level of DRP-1 in ABCG2-deﬁcicent hepatocytes
was signiﬁcant higher than wild-type hepatocytes. In contrast, the
level of phosphorylated DRP-1 (p-DRP-1) was higher in wild-type
hepatocytes than ABCG2-deﬁcicent hepatocytes. Although brief
ALA treatment was only found to slightly increase the level of
drp-1 (Fig. 4J). However, co-immunostaining of DRP-1 and Mito-
Tracker Red further revealed mitochondrial localization of DRP-1
was increased in ALA-treated hepatocytes compared to untreated
hepatocytes (Fig. 4K–N). In contrast, mitochondrial localization of
p-DRP-1 was reduced in ALA-treated hepatocytes compared to un-
treated hepatocytes (Fig. 4O–R). These ﬁndings further suggest that
increases in fragmental mitochondria in ABCG2-deﬁcient or ALA-
treated hepatocytes are possibly mediated by mitochondrial ﬁssion
regulator DRP-1 induced by PPIX accumulation.4. Discussion
In living cells, mitochondrial dynamics and functions are mod-
ulated by coordinated fusion and ﬁssion regulators that can change
an integrated mitochondrial reticular network into huge dispersed
mitochondria [15]. Environmental cues or metabolic stimuli may
induce changes in the mitochondrial dynamics that can lead to bio-
energetics ﬂuctuations [15,16]. We have shown here that ABCG2
knockout mice had impairments in glucose homeostasis, which
may be due to the increased amount of fragmented mitochondria
and reduced mitochondrial membrane potentials seen in ABCG2-
deﬁcient hepatocytes. This alteration in mitochondrial morpholog-
ical changes was mediated by PPIX accumulation and by DRP-1
(Fig. 4I, Supplementary Fig. 2A and B). ALA treatment was found
to not only elevate the cellular level of PPIX and accompanied by
disruption of mitochondrial fusion/ﬁssion balance in primary
hepatocytes, but also to increase mitochondrial localization of
DRP1 (Fig. 4K–N, Supplementary Fig. 2B). These ﬁndings further
suggest that increases in fragmental mitochondria in ABCG2-deﬁ-
cient hepatocytes are possibly mediated by DRP-1 induced by PPIX
accumulation. However, it is not clear how PPIX accumulation can
lead to increases in DRP-1-mediated mitochondrial ﬁssion.
Indeed, it has been shown that Drp-1 is a transcriptional target
of p53 [17] and mitochondrial oxidative stress can causesmitochondrial fragmentation [18]. Moreover, reactive oxygen spe-
cies (ROS) can be generated by oxidation of the porphyrin precur-
sor ALA [19] or by the fenton reaction involving PPIX [20]. We have
performed dichloro-dihydro-ﬂuorescein diacetate (DCFH-DA) as-
say for detection of ROS (Supplementary Fig. 2C). We found
ABCG2-deﬁcient hepatocytes had higher levels of ROS. Moreover,
ALA-treated hepatocytes also had a higher level of ROS compared
to untreated hepatocytes (Supplementary Fig. 2C). The results ex-
plained why PPIX accumulation can lead to increases in the level
of phosphorylated p53. Moreover, utilizing mouse liver FL83B cell
lines, we further demonstrated that treatment of FL83B cells ALA
caused nuclear translocation of phosphorylated p53 accompanied
by increases in mitochondrial fragmentation. In contrast, addition
of piﬁthrin-a (PT-a), a p53 inhibitor, could prevent mitochondria
ﬁssion induced by ALA treatment (Supplementary Fig. 3). We
therefore anticipate that PPIX accumulation in ABCG2 knockout
condition leads to increases in the level of ROS and activation of
p53 pathway which thereafter up-regulates DRP-1-mediated mito-
chondria ﬁssion.
It is established that ABCG2 transporters can extrude xenobiot-
ics and certain drugs from drug-resistant cancer cells [21], thereby
affecting the pharmacological behavior of many compounds such
as mitoxantrone, and doxorubicin. As such, ﬁnding a novel com-
pound that can suppress ABCG2 and restore drug sensitivity has
been recognized as a key goal for improving cancer therapeutics
[22]. However, the ﬁnding that ABCG2 deﬁciency can cause gener-
ation of dysfunctional mitochondria in hepatocytes should raises
concerns regarding the long-term use of ABCG2 inhibitor in cancer
patients.
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